Selective T Cell Costimulation Modulator [EPC]

135353 reported adverse events

Drugs of this class: ABATACEPT

These side effects are most commonly reported by patients taking drugs of the Selective T Cell Costimulation Modulator [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 38811
1 RHEUMATOID ARTHRITIS 23924
2 PAIN 21580
3 ARTHRALGIA 20718
4 JOINT SWELLING 20106
5 FATIGUE 14326
6 CONTRAINDICATED PRODUCT ADMINISTERED 13901
7 RASH 13127
8 DRUG INTOLERANCE 13109
9 OFF LABEL USE 11950
See all common reactions for Selective T Cell Costimulation Modulator [EPC]

Drugs of the Selective T Cell Costimulation Modulator [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 306 0.9162
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 5347 0.7838
2 RHEUMATOID FACTOR NEGATIVE 137 0.7829
3 RHEUMATOID FACTOR POSITIVE 4221 0.7551
4 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 483 0.7385
5 RED BLOOD CELL SEDIMENTATION RATE 204 0.7365
6 SWOLLEN JOINT COUNT INCREASED 2163 0.7330
7 PEMPHIGUS 8731 0.7309
8 DEVICE SAFETY FEATURE ISSUE 633 0.7088
9 RHEUMATIC FEVER 2927 0.7067
See all enriched reactions for Selective T Cell Costimulation Modulator [EPC]